Meanwhile, inhibiting HOXA11-AS notably increased miR-124-3p expression to attenuate the FSTL1/NF-κB axis, thus dampening the neuron damage, expression of inflammatory factors and NLRP3 inflammasome, thereby alleviating PD progression. This evidence concerns the gene FSTL1 and Parkinson disease.